110 related articles for article (PubMed ID: 20356698)
1. Susceptibility of Burkholderia pseudomallei to tigecycline and other antimicrobials.
Sam IC; See KH; Puthucheary SD
Diagn Microbiol Infect Dis; 2010 Jul; 67(3):308-9. PubMed ID: 20356698
[No Abstract] [Full Text] [Related]
2. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model.
Feterl M; Govan B; Engler C; Norton R; Ketheesan N
Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro susceptibility of Burkholderia pseudomallei to doripenem, ertapenem, tigecycline and moxifloxacin.
Harris P; Engler C; Norton R
Int J Antimicrob Agents; 2011 Jun; 37(6):547-9. PubMed ID: 21481571
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic susceptibility of 50 clinical isolates of Burkholderia pseudomallei from Singapore.
Sivalingam SP; Sim SH; Aw LT; Ooi EE
J Antimicrob Chemother; 2006 Nov; 58(5):1102-3. PubMed ID: 16951412
[No Abstract] [Full Text] [Related]
5. Burkholderia pseudomallei: in vitro susceptibility to some new and old antimicrobials.
Karunakaran R; Puthucheary SD
Scand J Infect Dis; 2007; 39(10):858-61. PubMed ID: 17852912
[TBL] [Abstract][Full Text] [Related]
6. Five-year surveillance for Burkholderia pseudomallei in Thailand from 2000 to 2004: prevalence and antimicrobial susceptibility.
Paveenkittiporn W; Apisarnthanarak A; Dejsirilert S; Trakulsomboon S; Thongmali O; Sawanpanyalert P; Aswapokee N
J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S46-52. PubMed ID: 21298845
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents.
Thibault FM; Hernandez E; Vidal DR; Girardet M; Cavallo JD
J Antimicrob Chemother; 2004 Dec; 54(6):1134-8. PubMed ID: 15509614
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of tigecycline against Burkholderia pseudomallei and Burkholderia thailandensis.
Thamlikitkul V; Trakulsomboon S
Antimicrob Agents Chemother; 2006 Apr; 50(4):1555-7. PubMed ID: 16569883
[TBL] [Abstract][Full Text] [Related]
9. Reduced susceptibility of Malaysian clinical isolates of Burkholderia pseudomallei to ciprofloxacin.
Liew FY; Tay ST; Puthucheary SD
Trop Biomed; 2011 Dec; 28(3):646-50. PubMed ID: 22433895
[TBL] [Abstract][Full Text] [Related]
10. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia.
Crowe A; McMahon N; Currie BJ; Baird RW
Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of biapenem against Burkholderia pseudomallei.
Thamlikitkul V; Trakulsomboon S
Int J Antimicrob Agents; 2010 May; 35(5):514. PubMed ID: 20188524
[No Abstract] [Full Text] [Related]
12. Antimicrobial susceptibility patterns of Burkholderia pseudomallei among melioidosis cases in Kedah, Malaysia.
Hassan MR; Vijayalakshmi N; Pani SP; Peng NP; Mehenderkar R; Voralu K; Michael E
Southeast Asian J Trop Med Public Health; 2014 May; 45(3):680-8. PubMed ID: 24974653
[TBL] [Abstract][Full Text] [Related]
13. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei from Thailand.
Saiprom N; Amornchai P; Wuthiekanun V; Day NP; Limmathurotsakul D; Peacock SJ; Chantratita N
Int J Antimicrob Agents; 2015 May; 45(5):557-9. PubMed ID: 25758020
[No Abstract] [Full Text] [Related]
14. Comparison between the antimicrobial susceptibility of Burkholderia pseudomallei to trimethoprim-sulfamethoxazole by standard disk diffusion method and by minimal inhibitory concentration determination.
Lumbiganon P; Tattawasatra U; Chetchotisakd P; Wongratanacheewin S; Thinkhamrop B
J Med Assoc Thai; 2000 Aug; 83(8):856-60. PubMed ID: 10998837
[TBL] [Abstract][Full Text] [Related]
15. Cases of melioidosis in a university teaching hospital in Malaysia.
Raja NS
J Microbiol Immunol Infect; 2008 Apr; 41(2):174-9. PubMed ID: 18473106
[TBL] [Abstract][Full Text] [Related]
16. Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei.
Dance DA; Davong V; Soeng S; Phetsouvanh R; Newton PN; Turner P
Int J Antimicrob Agents; 2014 Oct; 44(4):368-9. PubMed ID: 25245211
[No Abstract] [Full Text] [Related]
17. In vitro activity of sitafloxacin against Burkholderia pseudomallei.
Thamlikitkul V; Trakulsomboon S
Int J Antimicrob Agents; 2011 Oct; 38(4):364. PubMed ID: 21775108
[No Abstract] [Full Text] [Related]
18. Melioidosis: antibiogram of cases in Singapore 1987-2007.
Tan AL; Tan ML
Trans R Soc Trop Med Hyg; 2008 Dec; 102 Suppl 1():S101-2. PubMed ID: 19121668
[TBL] [Abstract][Full Text] [Related]
19. Interpreting Burkholderia pseudomallei disc diffusion susceptibility test results by the EUCAST method.
Dance DAB; Wuthiekanun V; Baird RW; Norton R; Limmathurotsakul D; Currie BJ
Clin Microbiol Infect; 2021 Jun; 27(6):827-829. PubMed ID: 33636339
[No Abstract] [Full Text] [Related]
20. The antibiotics of choice for the treatment of melioidosis in Indian set up.
Shaw T; Tellapragada C; Eshwara VK; Bhat HV; Mukhopadhyay C
Indian J Med Microbiol; 2016; 34(3):353-4. PubMed ID: 27514960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
